Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort

Abstract There is an urgent need for accurate and validated methods to measure plasma phosphorylated tau (p-Tau) biomarkers in Alzheimer’s disease (AD). In this study, we compared the performance of new commercially available plasma p-Tau217 assay developed by ALZpath to other established p-Tau assa...

Full description

Saved in:
Bibliographic Details
Main Authors: Divya Bali, Gemma Salvadó, Thomas G. Beach, Geidy E. Serrano, Alireza Atri, Eric M. Reiman, Andreas Jeromin, Oskar Hansson, Shorena Janelidze
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Acta Neuropathologica Communications
Subjects:
Alzheimer’s disease
Phosphorylated-tau
Amyloid plaques
Neurofibrillary changes
Online Access:https://doi.org/10.1186/s40478-025-02064-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40478-025-02064-2

Similar Items